CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD) (C-Term) Peptide
CRADD
Reactivité: Humain
BP
Sodium azide
N° du produit ABIN1381972
-
-
Antigène
Tous les produits CRADD
-
CRADD
(CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
-
Protein Region
-
C-Term
-
Origine
-
Humain
-
Application
-
Blocking Peptide (BP)
-
Attributs du produit
-
19 amino acids near the carboxy terminus of human RAIDD.
Human
-
-
-
Indications d'application
-
RAIDD peptide is used for blocking the activity of RAIDD.
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Concentration
-
200 μg/mL
-
Buffer
-
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
-
Agent conservateur
-
Sodium azide
-
Précaution d'utilisation
-
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
-
-20 °C
-
Date de péremption
-
12 months
-
-
Antigène
-
CRADD
(CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD))
-
Synonymes
-
cradd Peptide, MGC89035 Peptide, zgc:101717 Peptide, CRADD Peptide, DKFZp468A2219 Peptide, LOC100226369 Peptide, raidd Peptide, MGC78788 Peptide, MRT34 Peptide, RAIDD Peptide, CASP2 and RIPK1 domain containing adaptor with death domain Peptide, CASP2 and RIPK1 domain containing adaptor with death, gene 1 Peptide, CASP2 and RIPK1 domain containing adaptor with death, gene 2 S homeolog Peptide, CRADD Peptide, cradd.1 Peptide, cradd Peptide, cradd.2.S Peptide, Cradd Peptide
-